Natural History of Oppenheim's Dystonia (DYT1) in Israel

Abstract

The question of whether a fetus carrying the GAG deletion on the DYT1 gene responsible for Oppenheim's dystonia should be aborted is frequently raised. The objective of this study was to characterize the clinical spectrum and natural course of Oppenheim's dystonia in Israel. Thirty-three patients (19 male) with genetically confirmed Oppenheim's dystonia were evaluated. The Dystonia Rating Scale (maximum score 120) and the Disability Scale (maximum score 30) were used to score severity at the last visit. After a mean of 15.5 ± 13.8 years of symptoms, the mean Dystonia Rating Scale and Disability Scale scores were 22.7 ± 14.7 and 7.7 ± 4.3, respectively. Twenty-one patients (63.6%) have progressed into generalized dystonia. Five patients (15%) are wheelchair bound and three (9%) are using walking aids. All patients have normal cognitive function. Baclofen, trihexyphenidyl, and botulinum toxin were the drugs used. Nine patients (one patient had both) underwent neurosurgical intervention: thalamotomy for six (two bilateral) and pallidotomy for four (three bilateral). The bilateral pallidotomy provided only short-term benefit. The modern treatments combining drugs, botulinum toxin, and functional neurosurgery allow most patients with Oppenheim's dystonia to have independence and a relatively good quality of life. (J Child Neurol 2003;18:325—330).

Get full access to this article

View all access options for this article.

References

Ozelius L.J. , Hewett JW , Kramer PL , et al: Fine localization of dystonia gene (DYT1) on human chromosome 9q34:YAC map and linkage disequilibrium. Genome Res 1997;7:483—496.

Falik Zaccai TC , Shachak E. , Badarny S. , et al: Oppenheim's dystonia: Clinical and molecular characterization of patients from different ethnic groups in Israel . Neurology 1998;50(Suppl 4):A132.

Ozelius L.J. , Hewett JW , Page C. , et al: The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40—48.

Augood SJ , Martin DM , Ozelius L.J. , et al: Distribution of m-RNAs encoding torsion A and torsion B in the normal adult brain. Ann Neurol 1999;46:761—769.

Korczyn AD , Kahana E. , Zilber N. , et al: Torsion dystonia in Israel. Ann Neurol 1980;8:387—391.

Bressman SB , de Leon D. , Brin MF , et al: Idiopathic torsion dystonia among 6 Ashkenazi Jews: Evidence for autosomal dominant inheritance. Ann Neurol 1989;26:612—620.

Zilber N. , Korczyn AD , Kahana E. , et al: Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984;21:13—20.

Risch N. , de Leon D. , Ozelius L. , et al: Genetic analysis of idiopathic torsion dystonia in Ashkenazy Jews and their recent descendent from a small founder population. Nat Genet 1995;9:152—159.

Ozelius L.J. , Kramer PL , de Leon D. , et al: Strong allelic association between the torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazy Jews. Am J Hum Genet 1992;50:619—628.

10.

Bressman SB , Sabatti C. , Raymond D. , et al: The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000;54:1746—1752.

11.

Bressman SB , de Leon D. , Kremer PL , et al: Dystonia in Ashkenazy Jews: Clinical characterization of a founder mutation. Ann Neurol 1994;36:771—777.

12.

Inzelberg R. , Zilber N. , Kahana E. , et al: Laterality of onset in idiopathic torsion dystonia. Mov Disord 1993;8:327—330.

13.

Almasy L. , Bressman S. , de Leon D. , et al: Ethnic variation in the clinical expression of idiopathic torsion dystonia. Mov Disord 1997;12:715—721.

14.

Green P. , Kang UJ , Fahn S. : Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995;10:143—152.

15.

Scott BL : Evaluation and treatment of dystonia. South Med J 2000;93:746—751.

16.

Adler CH : Strategies for controlling dystonia. Postgrad Med 2000;108:151—160.

17.

Cooper IS : Neurosurgical treatment of dystonia. Neurology 1970;20:133—148.

18.

Tasker RR , Doorly T. , Yamashiro K. : Thalamotomy in generalized dystonia. Adv Neurol 1988;50:615—631.

19.

Lin JJ , Lin SZ , Lin GY , et al: Treatment of intractable generalized dystonia by bilateral posteroventral pallidotomy—one year results. Zhonghua Yi Cue SA Hz (Taipei) 2001;64:231—238.

20.

Teive HA , Sa DS , Grande CV , et al: Bilateral pallidotomy for generalized dystonia. Arq Neuropsiquiatr 2001;59:353—357.

21.

Lai T. , Lai J. , Grossman RG : Functional recovery after bilateral pallidotomy for the treatment of early-onset primary generalized dystonia. Arch Phys Med Rehabil 1999;80:1340—1342.

22.

Ondo WG , Desaloms JM , Jankovic J. , et al: Pallidotomy for generalized dystonia. Mov Disord 1998;13:693—698.

23.

Lozano AM , Kumar R. , Gross RE , et al: Globus pallidus internus pallidotomy for generalized dystonia . Mov Disord 1997;12:865—870.

24.

Cardoso F. , Jankovic J. , Grossman RG , et al: Outcome after stereo-tactic thalamotomy for dystonia and hemiballismus . Neurosurgery 1995;36:501—507.

25.

Burke RE , Fahn S. , Marsden CD , et al: Validation and reliability of rating scale for the primary torsion dystonias. Neurology 1985;35:73—77.

26.

Inzelberg R. , Kahana E. , Korczyn AD : Clinical course of idiopathic torsion dystonia among Jews in Israel. Adv Neurol 1988;50:93—100.

27.

Byl NN , Merzenich MM , Jenkins WM : A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology 1996; 47:508—520.

28.

Greene P. : Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992;15:276—288.

29.

Fahn S. : High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255—1261.

30.

Favre J. , Burchiel KJ , Taha JM , et al: Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: Patient assessment. Neurosurgery 2000;46:344—353.

31.

Vercueil L. , Pollak P. , Fraix V. , et al: Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001;248:695—700.